Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules.
Cameron
C
C
Immunisation Department, Health Protection Agency Centre for Infections, London, United Kingdom. claire.cameron@hpa.org.uk
Pebody
R
R
D002648:Child; D002675:Child, Preschool; D003140:Communicable Disease Control / Q000458:organization & administration*; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D004334:Drug Administration Schedule; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D007117:Immunization, Secondary / Q000379:methods; D015994:Incidence; D008583:Meningitis, Haemophilus / Q000453:epidemiology / Q000517:prevention & control*; D008586:Meningitis, Pneumococcal / Q000453:epidemiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D011159:Population Surveillance; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D006113:United Kingdom / Q000453:epidemiology; D014611:Vaccination / Q000706:statistics & numerical data*; D018074:Vaccines, Conjugate / Q000627:therapeutic use*
D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate